What is a nursing priority to prevent complications in clients with respiratory acidosis

    At NURSING.com, we believe Black Lives Matter ✊🏿, No Human Is Illegal 🤝, Love Is Love 🏳️‍🌈, Women`s Rights Are Human Rights 👩, Science Is Real 🔬, Water Is Life 🌊, Injustice Anywhere Is A Threat To Justice Everywhere ☮️.

    AccessibilitySitemapDrug List

    Overview

    Practice Essentials

    Respiratory acidosis is an acid-base balance disturbance due to alveolar hypoventilation. Production of carbon dioxide occurs rapidly and failure of ventilation promptly increases the partial pressure of arterial carbon dioxide (PaCO2). [1] The normal reference range for PaCO2 is 35-45 mm Hg. [2, 3]

    Alveolar hypoventilation leads to an increased PaCO2 (ie, hypercapnia). The increase in PaCO2, in turn, decreases the bicarbonate (HCO3–)/PaCO2 ratio, thereby decreasing the pH. Hypercapnia and respiratory acidosis ensue when impairment in ventilation occurs and the removal of carbon dioxide by the respiratory system is less than the production of carbon dioxide in the tissues.

    Lung diseases that cause abnormalities in alveolar gas exchange do not typically result in alveolar hypoventilation. Often these diseases stimulate ventilation and hypocapnia due to reflex receptors and hypoxia. Hypercapnia typically occurs late in the disease process with severe pulmonary disease or when respiratory muscles fatigue. (See also Pediatric Respiratory Acidosis, Metabolic Acidosis, and Pediatric Metabolic Acidosis.)

    Acute vs chronic respiratory acidosis

    Respiratory acidosis can be acute or chronic. In acute respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range (ie, >45 mm Hg) with an accompanying acidemia (ie, pH < 7.35). In chronic respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range, with a normal or near-normal pH secondary to renal compensation and an elevated serum bicarbonate levels (ie, >30 mEq/L).

    Acute respiratory acidosis is present when an abrupt failure of ventilation occurs. This failure in ventilation may result from depression of the central respiratory center by one or another of the following:

    • Central nervous system disease or drug-induced respiratory depression

    • Inability to ventilate adequately, due to a neuromuscular disease or paralysis (eg, myasthenia gravis, amyotrophic lateral sclerosis [ALS], Guillain-Barré syndrome, muscular dystrophy)

    Chronic respiratory acidosis may be secondary to many disorders, including COPD. Hypoventilation in COPD involves multiple mechanisms, including the following:

    • Decreased responsiveness to hypoxia and hypercapnia

    • Increased ventilation-perfusion mismatch leading to increased dead space ventilation

    • Decreased diaphragmatic function due to fatigue and hyperinflation

    Chronic respiratory acidosis also may be secondary to obesity hypoventilation syndrome (OHS—ie, Pickwickian syndrome), neuromuscular disorders such as ALS, and severe restrictive ventilatory defects such as are observed in interstitial fibrosis and thoracic skeletal deformities.

    Workup in respiratory acidosis

    Arterial blood gas (ABG) analysis is necessary in the evaluation of a patient with suspected respiratory acidosis or other acid-base disorders. [4]

    The most common abnormal serum electrolyte finding in chronic respiratory acidosis is the presence of a compensatory increase in serum bicarbonate concentration.

    A thyrotropin and a free T4 level should be considered in selected patients, since hypothyroidism may cause obesity, leading to obstructive sleep apnea (OSA) and sleep apnea–related hypoventilation.

    Many patients with chronic hypercapnia and respiratory acidosis are also hypoxemic. These patients may have secondary polycythemia, as demonstrated by elevated hemoglobin and hematocrit values.

    In patients without an obvious source of hypoventilation and respiratory acidosis, a drug screen should be performed. The effects of sedating drugs such as narcotics and benzodiazepines in depressing the central ventilatory drive and causing respiratory acidosis should be considered. These sedative drugs should be avoided, if possible, in patients with respiratory acidosis.

    Radiography, computed tomography (CT) scanning, and fluoroscopy of the chest may provide helpful information in determining causes of respiratory acidosis. Radiologic studies (CT scanning and magnetic resonance imaging [MRI]) of the brain should be considered if a central cause of hypoventilation and respiratory acidosis is suspected.

    Pulmonary function test measurements are required for the diagnosis of obstructive lung disease and for assessment of the severity of disease. Forced expiratory volume in 1 second (FEV1.0) is the most commonly used index of airflow obstruction.

    Electromyography (EMG) and measurement of nerve conduction velocity (NCV) are useful in diagnosing neuromuscular disorders (eg, myasthenia gravis, Guillain-Barré syndrome, and amyotrophic lateral sclerosis [ALS]), which can cause ventilatory muscle weakness.

    Measurement of transdiaphragmatic pressure is a useful diagnostic test for documenting respiratory muscle weakness. However, it is difficult to perform and is usually carried out only in specialized pulmonary function laboratories.

    Management of respiratory acidosis

    Pharmacologic therapies are generally used as treatment for the underlying disease process. Oxygen therapy is employed to prevent the sequelae of long-standing hypoxemia.

    Therapeutic measures that may be lifesaving in severe hypercapnia and respiratory acidosis include endotracheal intubation with mechanical ventilation and noninvasive positive pressure ventilation (NIPPV) techniques such as nasal continuous positive-pressure ventilation (NCPAP) and nasal bilevel ventilation. The latter techniques of NIPPV are preferred treatment for obesity hypoventilation syndrome (OHS) and neuromuscular disorders, because they help to improve partial pressure of arterial oxygen (PaO2) and decrease the partial pressure of arterial carbon dioxide (PaCO2).

    Noninvasive external negative-pressure ventilation devices are also available for the treatment of selected patients with chronic respiratory failure.

    Rapid correction of the hypercapnia by the application of external noninvasive positive-pressure ventilation or invasive mechanical ventilation can result in alkalemia. Accordingly, these techniques should be used with caution.

    Etiology and Pathophysiology

    As noted (see Background), respiratory acidosis may have a variety of different causes, including the following:

    • COPD – Emphysema, chronic bronchitis, severe asthma [5, 6]

    • Neuromuscular diseases – ALS, diaphragm dysfunction and paralysis, Guillain-Barré syndrome, myasthenia gravis, muscular dystrophy, botulism

    • Chest wall disorders – Severe kyphoscoliosis, status post thoracoplasty, flail chest, and, less commonly, ankylosing spondylitis, pectus excavatum, [7] or pectus carinatum

    • Obesity-hypoventilation syndrome

    • Obstructive sleep apnea (OSA)

    • Central nervous system (CNS) depression – Drugs (eg, narcotics, barbiturates, benzodiazepines, and other CNS depressants), neurologic disorders (eg, encephalitis, brainstem disease, and trauma), primary alveolar hypoventilation, or congenital central alveolar hypoventilation syndrome (Ondine curse)

    • Other lung and airway diseases – Laryngeal and tracheal stenosis, interstitial lung disease

    • Lung-protective mechanical ventilation with permissive hypercapnia in the treatment of acute respiratory distress syndrome (ARDS); these patients typically are heavily sedated and may require paralytic agents

    • Acute respiratory acidosis may develop rapidly during bronchoscopy-guided percutaneous dilation tracheostomy from a reduced minute ventilation (aimed at lung-protective ventilation) [8]

    • Hypermetabolic states such as sepsis, malignant hyperthermia, thyroid crisis, fever, and overfeeding can elevate carbon dioxide levels; similarly, administration of bicarbonate to buffer acidosis or citrate-containing anticoagulants used in dialysis may lead to elevated partial arterial pressure of carbon dioxide (PaCO2) levels; these may result in the development of acute respiratory acidosis in the critically ill patient [9]

    A study by Alfano et al of over 200 patients with coronavirus disease 2019 (COVID-19) found the rate of respiratory acidosis to be 3.3%. Among the acid-base disturbances in this cohort, metabolic alkalosis had the highest prevalence (33.6%), followed by respiratory alkalosis (30.3%), combined alkalosis (9.4%), respiratory acidosis, and metabolic acidosis (2.8%). In addition, 3.6% of patients had other compensated acid-base derangements (3.6%). Overall, about 80% of patients in the cohort had an acid-base condition. [10]

    Metabolism

    Metabolism rapidly generates a large quantity of volatile acid (carbon dioxide) and nonvolatile acid. The metabolism of fats and carbohydrates leads to the formation of a large amount of carbon dioxide. The carbon dioxide combines with water to form carbonic acid (H2 CO3). The lungs excrete the volatile fraction through ventilation, and normally acid accumulation does not occur. [11]

    A significant alteration in ventilation that affects elimination of carbon dioxide can cause a respiratory acid-base disorder. The PaCO2 is normally maintained within the range of 35-45 mm Hg. [12, 13]

    Alveolar ventilation

    Alveolar ventilation is under the control of the central respiratory centers, which are located in the pons and the medulla. Ventilation is influenced and regulated by chemoreceptors for PaCO2, partial pressure of arterial oxygen (PaO2), and pH located in the brainstem, as well as by neural impulses from lung-stretch receptors and impulses from the cerebral cortex. Failure of ventilation quickly results in an increase in the PaCO2.

    Physiologic compensation

    In acute respiratory acidosis, the body’s compensation occurs in 2 steps. The initial response is cellular buffering that takes place over minutes to hours. Cellular buffering elevates plasma bicarbonate values, but only slightly (approximately 1 mEq/L for each 10-mm Hg increase in PaCO2). The second step is renal compensation that occurs over 3-5 days. With renal compensation, renal excretion of carbonic acid is increased, and bicarbonate reabsorption is increased.

    The expected change in serum bicarbonate concentration in respiratory acidosis can be estimated as follows:

    • Acute respiratory acidosis – Bicarbonate increases by 1 mEq/L for each 10-mm Hg rise in PaCO2.The acute change in bicarbonate is, therefore, relatively modest and is generated by the blood, extracellular fluid, and cellular buffering system.

    • Chronic respiratory acidosis – Bicarbonate increases by 3.5 mEq/L for each 10-mm Hg rise in PaCO2. The greater change in bicarbonate in chronic respiratory acidosis is accomplished by the kidneys. The response begins soon after the onset of respiratory acidosis but requires 3-5 days to become complete.

    The expected change in pH with respiratory acidosis can be estimated with the following equations:

    • Acute respiratory acidosis – Change in pH = 0.008 × (40 – PaCO2)

    • Chronic respiratory acidosis – Change in pH = 0.003 × (40 – PaCO2)

    Electrolyte levels

    Respiratory acidosis does not have a great effect on serum electrolyte levels. Some small effects occur in calcium and potassium levels. Acidosis decreases binding of calcium to albumin and tends to increase serum ionized calcium levels. In addition, acidemia causes an extracellular shift of potassium. [14] Respiratory acidosis, however, rarely causes clinically significant hyperkalemia.

    1. Murray J, Nadel J. Hypoventilation syndromes. Textbook of Respiratory Medicine. 4th ed. Philadelphia, Pa: WB Saunders; 2005. Vol 2: 2075-80.

    2. Patel S, Sharma S. Respiratory Acidosis. StatPearls. 2021 Jan. [QxMD MEDLINE Link]. [Full Text].

    3. Hopkins E, Sanvictores T, Sharma S. Physiology, Acid Base Balance. StatPearls. 2021 Jan. [QxMD MEDLINE Link]. [Full Text].

    4. Castro D, Keenaghan M. Arterial Blood Gas. StatPearls. 2018 Jan. [QxMD MEDLINE Link]. [Full Text].

    5. Adnet F, Plaisance P, Borron SW, Levy A, Payen D. Prolonged severe hypercapnia complicating near fatal asthma in a 35-year-old woman. Intensive Care Med. 1998 Dec. 24(12):1335-8. [QxMD MEDLINE Link].

    6. Cham GW, Tan WP, Earnest A, Soh CH. Clinical predictors of acute respiratory acidosis during exacerbation of asthma and chronic obstructive pulmonary disease. Eur J Emerg Med. 2002 Sep. 9(3):225-32. [QxMD MEDLINE Link].

    7. Theerthakarai R, El-Halees W, Javadpoor S, Khan MA. Severe pectus excavatum associated with cor pulmonale and chronic respiratory acidosis in a young woman. Chest. 2001 Jun. 119(6):1957-61. [QxMD MEDLINE Link].

    8. Karagiannidis C, Merten ML, Heunks L, et al. Respiratory acidosis during bronchoscopy-guided percutaneous dilatational tracheostomy: impact of ventilator settings and endotracheal tube size. BMC Anesthesiol. 2019 Aug 9. 19 (1):147. [QxMD MEDLINE Link]. [Full Text].

    9. Kallet RH. A Comprehensive Review of Prone Position in ARDS. Respir Care. 2015 Nov. 60 (11):1660-87. [QxMD MEDLINE Link]. [Full Text].

    10. Alfano G, Fontana F, Mori G, et al. Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2021 Jun 11. [QxMD MEDLINE Link]. [Full Text].

    11. Kellum JA. Determinants of plasma acid-base balance. Crit Care Clin. 2005 Apr. 21(2):329-46. [QxMD MEDLINE Link].

    12. Ehrsam RE, Heigenhauser GJ, Jones NL. Effect of respiratory acidosis on metabolism in exercise. J Appl Physiol. 1982 Jul. 53(1):63-9. [QxMD MEDLINE Link].

    13. Kazmaier S, Weyland A, Buhre W, et al. Effects of respiratory alkalosis and acidosis on myocardial blood flow and metabolism in patients with coronary artery disease. Anesthesiology. 1998 Oct. 89(4):831-7. [QxMD MEDLINE Link].

    14. Wiseman AC, Linas S. Disorders of potassium and acid-base balance. Am J Kidney Dis. 2005 May. 45(5):941-9. [QxMD MEDLINE Link].

    15. Zorrilla-Riveiro JG, Arnau-Bartes A, Rafat-Sellares R, Garcia-Perez D, Mas-Serra A, Fernandez-Fernandez R. Nasal flaring as a clinical sign of respiratory acidosis in patients with dyspnea. Am J Emerg Med. 2017 Apr. 35 (4):548-53. [QxMD MEDLINE Link].

    16. Pollock JM, Deibler AR, Whitlow CT, et al. Hypercapnia-Induced Cerebral Hyperperfusion: An Underrecognized Clinical Entity. AJNR Am J Neuroradiol. 2008 Oct 14. [QxMD MEDLINE Link].

    17. Lun CT, Tsui MS, Cheng SL, et al. Differences in baseline factors and survival between normocapnia, compensated respiratory acidosis and decompensated respiratory acidosis in COPD exacerbation: A pilot study. Respirology. 2016 Jan. 21 (1):128-36. [QxMD MEDLINE Link].

    18. de Miguel-Diez J, Jimenez-Garcia R, Hernandez-Barrera V, et al. Readmissions following an initial hospitalization by COPD exacerbation in Spain from 2006 to 2012. Respirology. 2016 Apr. 21 (3):489-96. [QxMD MEDLINE Link].

    19. Fazekas AS, Aboulghaith M, Kriz RC, et al. Long-term outcomes after acute hypercapnic COPD exacerbation : First-ever episode of non-invasive ventilation. Wien Klin Wochenschr. 2018 Jul 31. [QxMD MEDLINE Link].

    20. Crisafulli E, Ielpo A, Barbeta E, et al. Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study. Respir Res. 2018 Dec 27. 19 (1):261. [QxMD MEDLINE Link]. [Full Text].

    21. Mochizuki K, Fujii T, Paul E, et al. Acidemia subtypes in critically ill patients: An international cohort study. J Crit Care. 2021 Aug. 64:10-7. [QxMD MEDLINE Link].

    22. Sadot E, Gut G, Sivan Y. Alveolar ventilation in children during flexible bronchoscopy. Pediatr Pulmonol. 2016 Apr 8. [QxMD MEDLINE Link].

    23. Saunders R, Struys MMRF, Pollock RF, Mestek M, Lightdale JR. Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis. BMJ Open. 2017 Jun 30. 7 (6):e013402. [QxMD MEDLINE Link]. [Full Text].

    24. Wu JY, Kuo PH, Fan PC, Wu HD, Shih FY, Yang PC. The Role of Non-invasive Ventilation and Factors Predicting Extubation Outcome in Myasthenic Crisis. Neurocrit Care. 2009. 10(1):35-42. [QxMD MEDLINE Link].

    25. Zhang WB, Wang XY, Tian XY, Zhang H, Wang ZP, Gao YY. [Clinical value of noninvasive positive-pressure ventilation in chronic obstruction pulmonary disease combined with type II respiratory failure: a 4-year retrospective study]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Oct. 20(10):601-3. [QxMD MEDLINE Link].

    26. Fielding-Singh V, Matthay MA, Calfee CS. Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome. Crit Care Med. 2018 Sep 20. [QxMD MEDLINE Link].

    27. Nentwich J, Wichmann D, Kluge S, Lindau S, Mutlak H, John S. Low-flow CO2 removal in combination with renal replacement therapy effectively reduces ventilation requirements in hypercapnic patients: a pilot study. Ann Intensive Care. 2019 Jan 7. 9 (1):3. [QxMD MEDLINE Link]. [Full Text].

    28. Terragni PP, Birocco A, Faggiano C, Ranieri VM. Extracorporeal CO(2) Removal. Contrib Nephrol. 2010 April 20. 165:185-196. [QxMD MEDLINE Link]. [Full Text].

    What is a nursing priority to prevent complications in clients with respiratory acidosis

    What is a nursing priority to prevent complications in clients with respiratory acidosis

    Author

    Nazir A Lone, MD, MBBS, MPH, FACP, FCCP Physician in Pulmonary and Critical Care Medicine, Peconic Bay Medical Center, Northwell Health

    Nazir A Lone, MD, MBBS, MPH, FACP, FCCP is a member of the following medical societies: American Association for Bronchology and Interventional Pulmonology, American College of Chest Physicians, American College of Physicians, International Association for the Study of Lung Cancer, Medical Society of the State of New York, Society of Critical Care Medicine

    Disclosure: Nothing to disclose.

    Coauthor(s)

    Laurel Whitney MD Candidate, Columbia University College of Physicians and Surgeons

    Disclosure: Nothing to disclose.

    Chief Editor

    Zab Mosenifar, MD, FACP, FCCP Geri and Richard Brawerman Chair in Pulmonary and Critical Care Medicine, Professor and Executive Vice Chairman, Department of Medicine, Medical Director, Women's Guild Lung Institute, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

    Zab Mosenifar, MD, FACP, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Thoracic Society

    Disclosure: Nothing to disclose.

    Additional Contributors

    Ryland P Byrd, Jr, MD Professor of Medicine, Division of Pulmonary Disease and Critical Care Medicine, James H Quillen College of Medicine, East Tennessee State University

    Ryland P Byrd, Jr, MD is a member of the following medical societies: American College of Chest Physicians, American Thoracic Society

    Disclosure: Nothing to disclose.

    Thomas M Roy, MD Chief, Division of Pulmonary Disease and Critical Care Medicine, Quillen Mountain Home Veterans Affairs Medical Center; Professor of Medicine, Division of Pulmonary Disease and Critical Care Medicine, Fellowship Program Director, James H Quillen College of Medicine, East Tennessee State University

    Thomas M Roy, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, American Thoracic Society, Southern Medical Association, Wilderness Medical Society

    Disclosure: Nothing to disclose.

    Acknowledgements

    Wael El Minaoui, MBBS Fellow in Pulmonary/Critical Care Medicine, East Tennessee State University, James H Quillen College of Medicine

    Disclosure: Nothing to disclose.

    Jackie A Hayes, MD, FCCP Clinical Assistant Professor of Medicine, University of Texas Health Science Center at San Antonio; Chief, Pulmonary and Critical Care Medicine, Department of Medicine, Brooke Army Medical Center

    Jackie A Hayes, MD, FCCP is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, and American Thoracic Society

    Disclosure: Nothing to disclose.

    Oleh Wasyl Hnatiuk, MD Program Director, National Capital Consortium, Pulmonary and Critical Care, Walter Reed Army Medical Center; Associate Professor, Department of Medicine, Uniformed Services University of Health Sciences

    Oleh Wasyl Hnatiuk, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and American Thoracic Society

    Disclosure: Nothing to disclose.

    Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

    Disclosure: Medscape Salary Employment

    What nursing interventions are appropriate to prevent respiratory acidosis?

    Nursing Interventions & Considerations Maintain adequate hydration. Maintain patent airway and provide humidification if acidosis requires mechanical ventilation. Perform tracheal suctioning frequently and vigorous chest physiotherapy, if ordered.

    What is the priority of management in respiratory acidosis?

    Treatment is aimed at the underlying disease, and may include: Bronchodilator medicines and corticosteroids to reverse some types of airway obstruction. Noninvasive positive-pressure ventilation (sometimes called CPAP or BiPAP) or a breathing machine, if needed. Oxygen if the blood oxygen level is low.

    What nursing interventions should be done for patient with acid

    Medical Management / Nursing Interventions: Encourage the anxious patient to verbalize fears. Administer sedation as ordered to relax the patient. Keep the patient warm and dry. Encourage the patient to take deep, slow breaths or breathe into a brown paper bag (inspire CO2).

    What precautions should the nurse implement for the patient with metabolic acidosis to prevent potential injury?

    Nursing Interventions & Considerations Keep sodium bicarbonate ampules handy for emergency administration. Monitor vital signs, laboratory results and level of consciousness frequently. Watch out for signs of decreasing level of consciousness. Record intake and output accurately to monitor renal function.